| Reconstituted HDL in Acute Coronary Syndromes. | |
| | |
MedLine Citation:
|
PMID: 20840194 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Objectives: The strong inverse relationship between plasma high-density lipoprotein (HDL)-cholesterol and atherosclerotic cardiovascular disease provides the epidemiological basis that HDL is atheroprotective. Since HDL enhances cholesterol efflux and exhibits potent antiinflammatory properties, the aim of the present study was to investigate whether infusion of reconstituted HDL (rHDL) impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with acute coronary syndromes (ACS). Methods: Twenty-nine patients with ACS were randomized to double-blind treatment with rHDL or albumin. Endothelium-dependent and independent vasodilatation to intraarterial acetylcholine and sodium nitroprusside were measured by forearm venous occlusion plethysmography. In addition, oxidized LDL and high-sensitivity C-reactive protein were determined as markers of oxidative stress and vascular inflammation. Results: rHDL infusion increased plasma HDL (P < 0.0001) and decreased LDL (P < 0.0001). Oxidized LDL (P= 0.11), high-sensitivity C-reactive protein (P= 0.12) and the response to endothelium-dependent and -independent vasodilatators remained unchanged after rHDL compared to albumin infusion (14.9 ± 9.2 versus 14.5 ± 12.4, P= 0.93 and 12.8 ± 7.1 versus 13.2 ± 9.6, P= 0.27, respectively). Conclusions: An increase of HDL and a reduction of LDL notwithstanding, human rHDL did not improve vascular function in patients with ACS thus further challenging the clinical benefit of interventions, which rapidly raise HDL in ACS, particularly with the infusion of reconstituted HDL. |
| | |
Authors:
|
Rémy Chenevard; David Hürlimann; Lukas Spieker; Markus Béchir; Frank Enseleit; Matthias Hermann; Andreas J Flammer; Isabella Sudano; Roberto Corti; Thomas F Lüscher; Georg Noll; Frank Ruschitzka |
Related Documents
:
|
20934854 - Impact of high cholesterol intake on tissue cholesterol content and lipid transfers to ... 7282604 - Relationship of weight loss and cigarette smoking to changes in high-density lipoprotei... 9622274 - Delayed increase in high density lipoprotein-phospholipids after ingestion of a fat loa... 10208014 - High-density lipoprotein: multipotent effects on cells of the vasculature. 10230804 - Attenuation of galactose-induced cataract by pyruvate. 8225184 - Influence of sodium and potassium diets on adrenal vasopressin content and direct effec... |
Publication Detail:
|
Type: Journal Article Date: 2010-09-15 |
Journal Detail:
|
Title: Cardiovascular therapeutics Volume: 30 ISSN: 1755-5922 ISO Abbreviation: Cardiovasc Ther Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-03-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101319630 Medline TA: Cardiovasc Ther Country: England |
Other Details:
|
Languages: eng Pagination: e51-7 Citation Subset: IM |
Copyright Information:
|
© 2010 Blackwell Publishing Ltd. |
Affiliation:
|
Cardiovascular Center, Cardiology, University Hospital, Zurich, Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: PPAR-? Agonism for Cardiovascular and Renal Protection.
Next Document: Cognitive control in the intertrial interval: Evidence from EEG alpha power.